Retinitis pigmentosa, or RP, is a rare hereditary eye disorder which slowly robs people of their vision. In Canada, it affects 1 out of 4000 people – approximately 10000 Canadians live with it. Signs are noted by most individuals when they are children or teens. It has no cure yet, and patients have an opportunity
Canada’s healthcare system is widely respected for its quality, accessibility, and emphasis on patient-centered care. However, patients in Canada who face chronic, degenerative, or complex health conditions sometimes find that traditional treatment options only offer limited relief. This has led many individuals to explore regenerative medicine — especially stem cell therapy — as a promising
Advances in Glaucoma Optic Atrophy Treatment in Canada with Stem Cell Therapy Glaucoma is a type of eye disease. It negatively affects the nerve. This results in a condition referred to as optic atrophy. This damage can lead to blinding complications if not treated. While traditional approaches to managing glaucoma is to control intraocular pressure
Optic atrophy can provoke significant vision loss and thus negatively affecting the quality of life of patients. Since stem cell therapy is a good treatment solution, the clients should have an understanding of aftercare after the treatment procedure is done. Aftercare can help patient get the most of the treatment, promote healing and offer continuous
Stargardt’s or macular dystrophy is where the patient goes through certain treatment methods in an attempt to maintain his or her eyesight. Stem cells hold the possibility of major breakthroughs in treating this disease. But, when selecting a clinic for stem cell therapy, it is necessary to be very careful as it determines the effectiveness